Zoledronic Acid One bottle with 5 mg/100 ml
Generic Name: Zoledronic Acid
Therapeutic Class: Bisphosphonates
Indications
Zoledronic Acid is primarily indicated for the treatment of **Postmenopausal Osteoporosis** and to increase bone mass in men with osteoporosis. it is also used for:
- Treatment and prevention of glucocorticoid-induced osteoporosis.
- Treatment of **Paget's disease** of bone.
- Management of **Hypercalcemia of Malignancy** (high calcium levels caused by cancer).
- Reduction of bone damage (bone metastases) in patients with advanced cancers involving bone (such as multiple myeloma or prostate cancer).
Presentation
IV Infusion: It is usually available as a concentrated solution or a ready-to-use infusion bottle.
- **4 mg/5 ml** or **4 mg/100 ml** (for oncology indications).
- **5 mg/100 ml** (for osteoporosis and Paget's disease).
Description
Zoledronic Acid belongs to a group of medicines called bisphosphonates. It is a potent inhibitor of osteoclast-mediated bone resorption. It works by attaching to the bone and slowing down the cells that break down bone tissue (osteoclasts). This leads to an increase in bone mineral density and a reduction in serum calcium levels. In cancer patients, it helps prevent fractures and bone pain by maintaining bone strength.
Dosage & Administration
Zoledronic Acid must be administered by **Intravenous (IV) Infusion** over a period of no less than 15 minutes.
Osteoporosis (Postmenopausal or in Men): 5 mg once a year.
Paget's Disease: A single 5 mg infusion.
Hypercalcemia of Malignancy: 4 mg as a single infusion. It may be repeated if calcium levels do not normalize.
Note: Patients must be adequately hydrated before administration. Supplemental Calcium and Vitamin D should be taken if dietary intake is inadequate.
Osteoporosis (Postmenopausal or in Men): 5 mg once a year.
Paget's Disease: A single 5 mg infusion.
Hypercalcemia of Malignancy: 4 mg as a single infusion. It may be repeated if calcium levels do not normalize.
Note: Patients must be adequately hydrated before administration. Supplemental Calcium and Vitamin D should be taken if dietary intake is inadequate.
Side Effects
The most common side effects include fever, chills, bone pain, joint pain (arthralgia), and muscle pain (myalgia), often referred to as "flu-like symptoms." These usually occur within 3 days of the infusion. Other side effects may include nausea, fatigue, anemia, and headache. A serious but rare side effect is **Osteonecrosis of the Jaw (ONJ)**, particularly in cancer patients undergoing dental procedures.
Pregnancy & Lactation
Pregnancy: Zoledronic Acid is contraindicated during pregnancy. It may cause fetal harm, specifically affecting fetal bone development.
Lactation: It is not known whether Zoledronic Acid is excreted in human milk. It is recommended to avoid use during breastfeeding.
Lactation: It is not known whether Zoledronic Acid is excreted in human milk. It is recommended to avoid use during breastfeeding.
Precautions & Interactions
Precautions: Renal function (Serum Creatinine) must be monitored before each dose. It should be used with caution in patients with aspirin-sensitive asthma. Dental exams are recommended before starting treatment to minimize the risk of jaw osteonecrosis.
Interactions:
Interactions:
- **Aminoglycosides:** May have an additive effect in lowering serum calcium.
- **Diuretics (Loop diuretics):** Increased risk of hypocalcemia.
- **Nephrotoxic drugs:** Increased risk of kidney damage.
Overdose
Overdose may result in clinically significant hypocalcemia (low calcium), hypophosphatemia, and hypomagnesemia.
Treatment: Requires clinical monitoring and intravenous administration of calcium gluconate or relevant electrolytes to restore mineral levels.
Treatment: Requires clinical monitoring and intravenous administration of calcium gluconate or relevant electrolytes to restore mineral levels.
Storage
Store at a temperature below 30°C. Once the bottle is opened, the solution is stable for 24 hours at 2°C–8°C. Do not freeze. Keep out of reach of children.
.png)
